Sign Up to like & get
recommendations!
1
Published in 2022 at "European journal of endocrinology"
DOI: 10.1530/eje-21-0509
Abstract: NTRK rearrangements represent a very rare genomic abnormality among all cancers, but can be detected in thyroid cancer with a non-negligible frequency of 2%. Dramatic clinical responses to therapies targeting NTRK chimeric proteins are now…
read more here.
Keywords:
response larotrectinib;
thyroid carcinoma;
carcinoma harboring;
sqstm1 ntrk1 ... See more keywords